Enwei Pharmaceutical Co., Ltd. (SHE:301331)
China
· Delayed Price · Currency is CNY 28.57
+0.72 (2.59%)
At close: Mar 10, 2026
Enwei Pharmaceutical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Operating Revenue | 884.7 | 808.19 | 781.2 | 687.5 | 675.79 | 630.97 | Upgrade
|
| Other Revenue | 3.94 | 3.94 | 3.99 | 4.07 | 3.91 | 3.19 | Upgrade
|
| Revenue | 888.64 | 812.13 | 785.19 | 691.57 | 679.7 | 634.16 | Upgrade
|
| Revenue Growth (YoY) | 14.57% | 3.43% | 13.54% | 1.75% | 7.18% | 2.17% | Upgrade
|
| Cost of Revenue | 459.07 | 404.17 | 384.36 | 346.2 | 298.67 | 271.75 | Upgrade
|
| Gross Profit | 429.57 | 407.96 | 400.83 | 345.37 | 381.03 | 362.41 | Upgrade
|
| Selling, General & Admin | 358.71 | 342.52 | 292.84 | 258.17 | 264.71 | 244.19 | Upgrade
|
| Research & Development | 7.61 | 9.07 | 16.82 | 7.52 | 4.32 | 4.84 | Upgrade
|
| Other Operating Expenses | 13.38 | 12.56 | 10.89 | 9.89 | 11.64 | 10.35 | Upgrade
|
| Operating Expenses | 379.96 | 365.98 | 320.45 | 277.06 | 281.34 | 258.66 | Upgrade
|
| Operating Income | 49.6 | 41.98 | 80.38 | 68.31 | 99.69 | 103.76 | Upgrade
|
| Interest Expense | -3.2 | -2.43 | - | - | - | -0.06 | Upgrade
|
| Interest & Investment Income | 8.81 | 7.59 | 10.3 | 1.99 | 0.52 | 0.33 | Upgrade
|
| Other Non Operating Income (Expenses) | 3.12 | -0.08 | -0.66 | -0.27 | -0.88 | -2.16 | Upgrade
|
| EBT Excluding Unusual Items | 58.34 | 47.07 | 90.03 | 70.03 | 99.33 | 101.87 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | -0.44 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.47 | -0.26 | -0.04 | - | - | 0.01 | Upgrade
|
| Asset Writedown | 4.28 | -0.05 | - | - | -0.01 | -0.08 | Upgrade
|
| Other Unusual Items | 2.2 | -0.06 | 11.33 | 11.83 | 20.25 | 22.67 | Upgrade
|
| Pretax Income | 64.35 | 46.68 | 101.31 | 81.86 | 119.13 | 124.47 | Upgrade
|
| Income Tax Expense | 12.29 | 9.19 | 15 | 14.06 | 17.39 | 19.29 | Upgrade
|
| Earnings From Continuing Operations | 52.06 | 37.5 | 86.31 | 67.8 | 101.73 | 105.18 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | - | -6.44 | Upgrade
|
| Net Income | 52.06 | 37.5 | 86.31 | 67.8 | 101.73 | 98.74 | Upgrade
|
| Net Income to Common | 52.06 | 37.5 | 86.31 | 67.8 | 101.73 | 98.74 | Upgrade
|
| Net Income Growth | 47.07% | -56.56% | 27.30% | -33.36% | 3.03% | 19.55% | Upgrade
|
| Shares Outstanding (Basic) | 100 | 101 | 103 | 84 | 78 | 73 | Upgrade
|
| Shares Outstanding (Diluted) | 100 | 101 | 103 | 84 | 78 | 73 | Upgrade
|
| Shares Change (YoY) | -1.90% | -1.82% | 21.93% | 8.34% | 6.51% | -6.12% | Upgrade
|
| EPS (Basic) | 0.52 | 0.37 | 0.84 | 0.80 | 1.31 | 1.35 | Upgrade
|
| EPS (Diluted) | 0.52 | 0.37 | 0.84 | 0.80 | 1.31 | 1.35 | Upgrade
|
| EPS Growth | 49.92% | -55.75% | 4.40% | -38.49% | -3.27% | 27.35% | Upgrade
|
| Free Cash Flow | 32.89 | 28.69 | -50.04 | 38.8 | 49.36 | 47.36 | Upgrade
|
| Free Cash Flow Per Share | 0.33 | 0.28 | -0.49 | 0.46 | 0.63 | 0.65 | Upgrade
|
| Dividend Per Share | 0.530 | 0.180 | 0.540 | 1.600 | - | 0.875 | Upgrade
|
| Dividend Growth | -1.94% | -66.70% | -66.22% | - | - | 53.33% | Upgrade
|
| Gross Margin | 48.34% | 50.23% | 51.05% | 49.94% | 56.06% | 57.15% | Upgrade
|
| Operating Margin | 5.58% | 5.17% | 10.24% | 9.88% | 14.67% | 16.36% | Upgrade
|
| Profit Margin | 5.86% | 4.62% | 10.99% | 9.80% | 14.97% | 15.57% | Upgrade
|
| Free Cash Flow Margin | 3.70% | 3.53% | -6.37% | 5.61% | 7.26% | 7.47% | Upgrade
|
| EBITDA | 102.06 | 86.85 | 115.13 | 99.22 | 127.79 | 136.54 | Upgrade
|
| EBITDA Margin | 11.48% | 10.69% | 14.66% | 14.35% | 18.80% | 21.53% | Upgrade
|
| D&A For EBITDA | 52.46 | 44.87 | 34.75 | 30.91 | 28.1 | 32.79 | Upgrade
|
| EBIT | 49.6 | 41.98 | 80.38 | 68.31 | 99.69 | 103.76 | Upgrade
|
| EBIT Margin | 5.58% | 5.17% | 10.24% | 9.88% | 14.67% | 16.36% | Upgrade
|
| Effective Tax Rate | 19.10% | 19.68% | 14.81% | 17.18% | 14.60% | 15.50% | Upgrade
|
| Revenue as Reported | 888.64 | 812.13 | 785.19 | 691.57 | 679.7 | 634.16 | Upgrade
|
| Advertising Expenses | - | 96.67 | 69.92 | 44.22 | - | 30.92 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.